Please Wait.....
Report
Tissue Diagnostics: Technologies and Global Markets
Market Research Report I 2025-01-24 I 124 Pages I BCC Research
Description
Report Scope
The report provides an analysis of the tissue diagnostics market, along with a competitive landscape and profiles of leading companies that include their revenues, product portfolios and recent activities. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters should find useful information about market developments and trends.
The study segments the market on multiple bases. By product type, the market is segmented into instruments and reagents (reagents/test kits/consumables of tissue diagnostics).
By segment type, the market is divided into histopathology, which includes hematoxylin and eosin stains (H&E) and immunohistochemistry (IHC); molecular pathology, which includes in situ hybridization (ISH), polymerase chain reaction (PCR) and next-generation sequencing (NGS); microbiological testing, which includes general culture testing and antimicrobial susceptibility testing and identification (AST/ID); and digital pathology.
Regional market analysis is provided for all the major segments. The regions are North America; Europe; Asia-Pacific; Latin America; and Rest of the World (RoW), which in this report consists of the Middle East and Africa. The report also provides country-level analyses of markets and market segments.
The report covers only tissue sample-based tests. The liquid biopsy market; swab, saliva and urine-based tests; and the service testing market of tissue diagnostics are outside the scope of the report.
In this report, the tissue diagnostics market is segmented by:
Product type:
- Reagents.
- Instruments.
Segments:
- Histopathology (H&E, IHC).
- Molecular pathology (ISH, PCR and NGS).
- Microbiological testing (general culture testing, AST/ID testing) .
- Digital pathology.
Technology:
- H&E.
- IHC.
- ISH.
- PCR.
- NGS.
- Digital pathology.
Applications:
- Oncology.
- Tissue typing.
- Pathogen detection and AST.
End users:
- Professional laboratories.
- Emergency care units.
- Academic and research institutes.
Report Includes
- 40 data tables and 42 additional tables
- An analysis of the global market trends for tissue diagnostics, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by type of test, technology, application, end user and region
- Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of macroeconomic factors
- Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
- An analysis of patents, emerging trends and developments in the industry
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Company profiles of major players within the industry, including F. Hoffmann-La Roche Ltd., Danaher Corp., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and Illumina Inc.
Executive Summary
Summary:
The global market for tissue diagnostics is estimated to increase from $8.9 billion in 2024 to reach $12.4 billion by 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 through 2029.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Market Overview and Definitions
Immunohistochemistry (IHC)
In Situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
General Culture Testing
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Cancer Cases
Companion Diagnostics in Cancer Treatment
Importance of Early Cancer Testing
Raising Awareness of Early Signs of Cancer
Aging Population
Market Opportunities
Enhancing Access
Digital Pathology
Partnerships
Market Restraints
Cost of Tissue Diagnostic Tests
Competing Technologies
Turnaround Time
Market Challenges
Lack of Skilled Professionals
Complex Sample Preparation and Handling
Chapter 4 Emerging Technologies and Developments
Overview
Digital Pathology and AI Integration
3D Tissue Pathology and AI
Fluorescent In Situ Sequencing
Chapter 5 Tissue Diagnostics Testing Market
Segmentation Breakdown
Market Breakdown
Market Breakdown, by Product Type
Market Breakdown, by Technology
Market Breakdown, by Segment
Histopathology Market
Molecular Pathology Market
Microbiology Testing Market
Digital Pathology Market
Market Breakdown, by Application
Market Breakdown, by End User
Geographic Breakdown
Market Breakdown, by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World
Chapter 6 Competitive Intelligence
Industry Scenario
Competitive Landscape
Chapter 7 Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Appendix
Research Methodology
References
Acronyms
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOCARE MEDICAL LLC.
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
KONINKLIJKE PHILIPS N.V.
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
ZYTOVISION GMBH
List of Tables
Summary Table : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 1 : Global Incidence of All Cancers, by Region, 2022-2045
Table 2 : Cancer Cases, by Country, 2022
Table 3 : Incidence of Cancer, by Cancer Type, 2022
Table 4 : Cancer Treatments Based on Specific Tests
Table 5 : Global Tissue Diagnostics Market, Through 2029
Table 6 : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 7 : Global Tissue Diagnostics Market, by Technology, Through 2029
Table 8 : Global IHC Tissue Diagnostics Market, by Region, Through 2029
Table 9 : Global H&E and Special Stains Diagnostics Market, by Region, Through 2029
Table 10 : Global ISH Tissue Diagnostics Market, by Region, Through 2029
Table 11 : Global PCR Tissue Diagnostics Market, by Region, Through 2029
Table 12 : Global NGS Tissue Diagnostics Market, by Region, Through 2029
Table 13 : Global Digital Pathology Market, by Region, Through 2029
Table 14 : Global Tissue Diagnostics Market, by Segment Type, Through 2029
Table 15 : Global Histopathology Market, by Product Type, Through 2029
Table 16 : Global Histopathology Market, by Region, Through 2029
Table 17 : Global Molecular Pathology Market, by Product Type, Through 2029
Table 18 : Global Molecular Pathology Market, by Region, Through 2029
Table 19 : Global Microbiology Testing Market, by Product Type, Through 2029
Table 20 : Global Microbiology Testing Market, by Region, Through 2029
Table 21 : Global Digital Pathology Market, Through 2029
Table 22 : Global Digital Pathology Market, by Region, Through 2029
Table 23 : Global Tissue Diagnostics Market, by Application, Through 2029
Table 24 : Global Tissue Diagnostics Market, by End User, Through 2029
Table 25 : Global Tissue Diagnostics Market, by Region, Through 2029
Table 26 : North American Tissue Diagnostics Market, by Country, Through 2029
Table 27 : European Tissue Diagnostics Market, by Country, Through 2029
Table 28 : Asia-Pacific Tissue Diagnostics Market, by Country, Through 2029
Table 29 : Latin American Tissue Diagnostics Market, by Country, Through 2029
Table 30 : RoW Tissue Diagnostics Market, Through 2029
Table 31 : ESG: Environmental Overview
Table 32 : ESG: Social Overview
Table 33 : ESG: Governance Overview
Table 34 : Acronyms Used in this Report
Table 35 : Abbott: Company Snapshot
Table 36 : Abbott: Financial Performance, FY 2022 and 2023
Table 37 : Abbott: Product Portfolio
Table 38 : Agilent Technologies Inc.: Company Snapshot
Table 39 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 40 : Agilent Technologies Inc.: Product Portfolio
Table 41 : Agilent Technologies Inc.: News/Key Developments, 2024
Table 42 : BD: Company Snapshot
Table 43 : BD: Financial Performance, FY 2022 and 2023
Table 44 : BD: Product Portfolio
Table 45 : Biocare Medical LLC.: Company Snapshot
Table 46 : Biocare Medical LLC.: Product Portfolio
Table 47 : Biomerieux: Company Snapshot
Table 48 : Biomerieux: Financial Performance, FY 2022 and 2023
Table 49 : Biomerieux: Product Portfolio
Table 50 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 51 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 52 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 53 : Danaher Corp.: Company Snapshot
Table 54 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 55 : Danaher Corp.: Product Portfolio
Table 56 : Danaher Corp.: News/Key Developments, 2023
Table 57 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 58 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 59 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 60 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024
Table 61 : Illumina Inc.: Company Snapshot
Table 62 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 63 : Illumina Inc.: Product Portfolio
Table 64 : Illumina Inc.: News/Key Developments, 2024
Table 65 : Koninklijke Philips N.V.: Company Snapshot
Table 66 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 67 : Koninklijke Philips N.V.: Product Portfolio
Table 68 : Merck KGaA: Company Snapshot
Table 69 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70 : Merck KGaA: Product Portfolio
Table 71 : Myriad Genetics Inc.: Company Snapshot
Table 72 : Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023
Table 73 : Myriad Genetics Inc.: Product Portfolio
Table 74 : QIAGEN.: Company Snapshot
Table 75 : QIAGEN.: Financial Performance, FY 2022 and 2023
Table 76 : QIAGEN.: Product Portfolio
Table 77 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 78 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 80 : ZytoVision GmbH: Company Snapshot
Table 81 : ZytoVision GmbH: Product Portfolio
List of Figures
Summary Figure A : Global Tissue Diagnostics Market, by Product Type, 2021-2029
Summary Figure B : Shares of Global Market for Tissue Diagnostics, by Product Type, 2023
Figure 1 : Market Dynamics of Tissue Diagnostics
Figure 2 : Shares of All Cancer Cases, by Region, 2022
Figure 3 : Emerging Trends and Technologies in Tissue Diagnostics
Figure 4 : Shares of Global Market for Tissue Diagnostics, by Technology, 2023
Figure 5 : Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023
Figure 6 : Shares of Global Market for Histopathology, by Product Type, 2023
Figure 7 : Shares of Global Market for Molecular Pathology, by Product Type, 2023
Figure 8 : Shares of Global Market for Microbiology Testing, by Product Type, 2023
Figure 9 : Shares of Global Market for Tissue Diagnostics, by Application, 2023
Figure 10 : Shares of Global Market for Tissue Diagnostics, by End User, 2023
Figure 11 : Shares of Global Market for Tissue Diagnostics, by Region, 2023
Figure 12 : Shares of North American Market for Tissue Diagnostics, by Country, 2023
Figure 13 : Shares of European Market for Tissue Diagnostics, by Country, 2023
Figure 14 : Shares of Asia-Pacific Market for Tissue Diagnostics, by Country, 2023
Figure 15 : Shares of Latin American Tissue Diagnostics Market, by Country, 2023
Figure 16 : Shares of Global Market for Tissue Diagnostics, by Company, 2023
Figure 17 : ESG Pillars
Figure 18 : Advantages of ESG for Companies
Figure 19 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 20 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 21 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 22 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 23 : BD: Revenue Shares, by Business Unit, FY 2023
Figure 24 : BD: Revenue Shares, by Country/Region, FY 2023
Figure 25 : Biomerieux: Revenue Shares, by Business Unit, FY 2023
Figure 26 : Biomerieux: Revenue Shares, by Country/Region, FY 2023
Figure 27 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 28 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 29 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 30 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 31 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 32 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 33 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 34 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 35 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 36 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023
Figure 37 : Merck KGaA: Market Shares, by Business Unit, FY 2023
Figure 38 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 39 : Myriad Genetics Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40 : Myriad Genetics Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 41 : QIAGEN.: Revenue Shares, by Business Unit, FY 2023
Figure 42 : QIAGEN.: Revenue Shares, by Country/Region, FY 2023
Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 44 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security